Journal of Clinical Endocrinology & Metabolism, Vol 59, 1103-1108, Copyright © 1984 by Endocrine Society

ARTICLES

Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion

TH Schurmeyer, PC Avgerinos, PW Gold, WT Gallucci, TP Tomai, GB Cutler Jr, DL Loriaux and GP Chrousos

The responses of plasma immunoreactive ACTH (IR-ACTH), cortisol, GH, PRL, and LH to a single iv injection of 0.01-5 micrograms/kg human corticotropin-releasing factor (hCRF) were investigated in healthy volunteers. The lowest effective dose of hCRF was 0.5 micrograms/kg. hCRF caused brief pulse-like elevations of plasma IR-ACTH and cortisol without any effect on the plasma concentrations of GH, PRL, and LH. By contrast, ovine CRF (oCRF), given for comparison, produced long-lasting stimulation of the human pituitary-adrenal axis. The difference in duration of effect between hCRF and oCRF may be attributed to an approximately 3-4 times higher MCR of hCRF [7.9 +/- 1.2 (+/- SE) ml/kg min; n = 14] than oCRF (1.9 +/- 0.1 ml/kg min; n = 9) in man. No serious side effects occurred at any of the doses of hCRF tested. The highest dose (5 micrograms/kg) caused a slight increase of heart rate that was not associated with significant changes in arterial blood pressure. All subjects receiving 5 micrograms/kg and one third of the subjects receiving 1 micrograms/kg hCRF experienced a transient facial flush. We conclude that hCRF causes brief plasma ACTH and cortisol secretory episodes in man, similar to the physiological plasma ACTH and cortisol secretory episodes. This is in contrast to oCRF, which causes prolonged ACTH and cortisol secretion. These differences between the two peptides may be explained by the higher MCR of hCRF than oCRF.

This article has been cited by other articles:

				A. Iranmanesh, P. C. Carpenter, K. Mielke, C. Y. Bowers, and J. D. Veldhuis Putative Somatostatin Suppression Potentiates Adrenocorticotropin Secretion Driven by Ghrelin and Human Corticotropin-Releasing Hormone J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3653 - 3659. [Abstract] [Full Text] [PDF]

				G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, A. Iranmanesh, K. Mielke, J. M. Miles, P. C. Carpenter, and C. Y. Bowers Ghrelin Potentiates Growth Hormone Secretion Driven by Putative Somatostatin Withdrawal and Resists Inhibition by Human Corticotropin-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2441 - 2446. [Abstract] [Full Text] [PDF]

				D. A. van Tijn, J. J. M. de Vijlder, B. Verbeeten Jr., P. H. Verkerk, and T. Vulsma Neonatal Detection of Congenital Hypothyroidism of Central Origin J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3350 - 3359. [Abstract] [Full Text] [PDF]

				G. MASTORAKOS and I. ILIAS Maternal and Fetal Hypothalamic-Pituitary-Adrenal Axes During Pregnancy and Postpartum Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 136 - 149. [Abstract] [Full Text] [PDF]

				I. L. Schmidt, H. Lahner, K. Mann, and S. Petersenn Diagnosis of Adrenal Insufficiency: Evaluation of the Corticotropin-Releasing Hormone Test and Basal Serum Cortisol in Comparison to the Insulin Tolerance Test in Patients with Hypothalamic-Pituitary-Adrenal Disease J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4193 - 4198. [Abstract] [Full Text] [PDF]

				J. A. Yanovski, S. Z. Yanovski, A. J. Boyle, P. W. Gold, K. N. Sovik, N. G. Sebring, and B. Drinkard Hypothalamic-Pituitary-Adrenal Axis Activity during Exercise in African American and Caucasian Women J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2660 - 2663. [Abstract] [Full Text]

				G. Lac, P. Marquet, A. P. Chassain, and F. X. Galen Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones J Appl Physiol, July 1, 1999; 87(1): 183 - 188. [Abstract] [Full Text] [PDF]

				I. J. ELENKOV, E. L. WEBSTER, D. J. TORPY, and G. P. CHROUSOS Stress, Corticotropin-Releasing Hormone, Glucocorticoids, and the Immune/Inflammatory Response: Acute and Chronic Effects Ann. N.Y. Acad. Sci., June 22, 1999; 876(1): 1 - 13. [Abstract] [Full Text] [PDF]

				L. Ghizzoni, G. Mastorakos, A. Vottero, A. Barreca, M. Furlini, A. Cesarone, B. Ferrari, G. P. Chrousos, and S. Bernasconi Corticotropin-Releasing Hormone (CRH) Inhibits Steroid Biosynthesis by Cultured Human Granulosa-Lutein Cells in a CRH and Interleukin-1 Receptor-Mediated Fashion Endocrinology, November 1, 1997; 138(11): 4806 - 4811. [Abstract] [Full Text] [PDF]

				P. C. Ng, G. W. K. Wong, C. W. K. Lam, C. H. Lee, T. F. Fok, M. Y. Wong, W. Wong, and D. C. F. Chan Pituitary-Adrenal Suppression and Recovery in Preterm Very Low Birth Weight Infants after Dexamethasone Treatment for Bronchopulmonary Dysplasia J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2429 - 2432. [Abstract] [Full Text] [PDF]

				P. C. Ng, G. W. K. Wong, C. W. K. Lam, C. H. Lee, M. Y. Wong, T. F. Fok, W. Wong, and D. C. F. Chan The Pituitary-Adrenal Responses to Exogenous Human Corticotropin-Releasing Hormone in Preterm, Very Low Birth Weight Infants J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 797 - 799. [Abstract] [Full Text] [PDF]

				D. L. Metzger, J. R. Kerrigan, and A. D. Rogol The Short-Term Infusion of Ovine Corticotropin-Releasing Hormone Does Not Alter Luteinizing Hormone Concentrations in Young Adult Men J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 697 - 700. [Abstract] [Full Text] [PDF]

				L. S. Constine, P. D. Woolf, D. Cann, G. Mick, K. McCormick, R. F. Raubertas, and P. Rubin Hypothalamic-Pituitary Dysfunction after Radiation for Brain Tumors N. Engl. J. Med., January 14, 1993; 328(2): 87 - 94. [Abstract] [Full Text]

				K Karalis, H Sano, J Redwine, S Listwak, R. Wilder, and G. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science, October 18, 1991; 254(5030): 421 - 423. [Abstract] [PDF]